Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MACHINE-DRUG

Financiado

Cerrado

Implementation of new machine learning algorithms for the optimisation of drug f...

Implementation of new machine learning algorithms for the optimisation of drug formulations Correctly developing and predicting crystalline forms with specific physico-chemical properties is essential to the pharmaceutical industry. The main challenge this industry faces is the fact that most active pharmaceutical ingred... ver más

31/03/2025

uni.lu

Presupuesto desconocido

Líder del proyecto

UNIVERSITE DU LUXEMBOURG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-10-01

ERC-2023-POC: ERC PROOF OF CONCEPT GRANTS Objective:Objectives:The ERC Proof of Concept Grants aim at facilitating exploration of the commerci...

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

uni.lu

Lider

Proyectos interesantes

PTQ2023-013180

Medical Technol...

Data Science

115K€ Cerrado

PTQ-09-02-01379

Medical Technol...

Data Science

28K€ Cerrado

MELLODDY

Medical Technol...

Data Science

19M€ Cerrado

FutForm

Medical Technol...

Data Science

414K€ Cerrado

PTQ-12-05650

Medical Technol...

Data Science

107K€ Cerrado

BES-2010-036573

Medical Technol...

Data Science

43K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 17 meses Fecha Inicio: 2023-10-01
Fecha Fin: 2025-03-31

Líder del proyecto

UNIVERSITE DU LUXEMBOURG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Correctly developing and predicting crystalline forms with specific physico-chemical properties is essential to the pharmaceutical industry. The main challenge this industry faces is the fact that most active pharmaceutical ingredients in most drugs can interconvert into a different (usually more stable) polymorph, potentially reducing the solubility of the drug, slowing down the release of the API and affecting the pharmacokinetics, bioavailability and efficacy of the drug. For instance, due to the complex interplay between thermodynamics and kinetics, it often happens that unexpected polymorphs emerge either in development (best case scenario) or long after the drug has been approved for market (worst case scenario). A previously known stable form that disappears or the sudden appearance of an even more stable form can have grave consequences. For instance, the new form may have new properties that are not suitable for the intended purpose of the drug, leading to significant economic and public health repercussions. This ERC Proof of Concept project aims to implement new machine learning approaches that would allow to accelerate the process of predicting crystal structures by a factor of 100, thereby making it sustainable and enabling industry to investigate other crystal structures of the same drug to find the most suitable formulation (e.g. hydrates, salts, co-crystals, etc). Beyond pharma (which is our target application for MACHINE-DRUG), polymorphism of chemical structures has significant importance across many other different industries. For instance, the polymorphism of a pigment can generate a different colour, or the polymorphism of a chemical structure can lead to a material with significantly different properties (thermal, plastic, etc.). As such, MACHINE-DRUG is a lean, targeted project with a clear scope, but its potential applications are limitless.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores